ReviewBiochemical pharmacology2010

Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.

Chunling Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.